Patient Home Monitoring Announces Date and Time for Quarterly Conference Call
LAFAYETTE, LOUISIANA--(Marketwired - May 22, 2017) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT
CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a healthcare services company in the US, announced today that it
will host its Quarterly Conference Call on Wednesday, May 24, 2017 at 4:15p.m. EST.
PHM's Quarterly conference will review Q2 of FY 2017 and update the market on plans for 2017 and beyond at 4:15p.m.
EST on Wednesday, May 24, 2017.
Conference Call Details
|
The details of the call are: |
|
Wednesday, May 24, 2017 at 4:15p.m. EST |
|
US & Canada Toll Free: |
|
Dial In: (888) 394-8218 |
|
Meeting ID Number: 530 26 51 |
Financial professionals are invited to call in to register in advance to ask questions. To pre-register as a
qualified caller, please e-mail investorinfo@myphm.com by 12
p.m. EST Wednesday, May 24, 2017.
About PHM
The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide
more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that
can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills
this need by delivering a growing number of specialized products and services to achieve these goals. PHM is company that serves
patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic
growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill
patients with multiple disease states caused mainly by age and obesity. PHM's post acquisition organic growth strategy is to
increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and
making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies
of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.